BACKGROUND: Shared decision making (SDM) and adherence to treatment are an integral part of multiple sclerosis (MS) care. A collaborative process, SDM actively involves the patient, the health care provider, and an extended network in making treatment decisions. Adherence to disease-modifying drug therapies in patients with MS presents an ongoing challenge for patients and health care providers due to the chronic nature of this disease. This narrative review aims to explore the impact of SDM on adherence based on existing literature and to identify new approaches to optimizing adherence. METHODS: A search was conducted using medical subject heading terms, including decision-making, adherence, shared decision-making, compliance, and patient-centered care. RESULTS: Shared decision making between patients and clinicians promotes adherence to the treatment plan in MS. A proactive SDM approach is based on patient preferences, education, and engagement. Providing credible and accurate sources of information is essential for improving patient engagement. Home monitoring, computerized models, and active patient engagement are a few new approaches to improve adherence in patients with MS. CONCLUSIONS: Shared decision-making interventions can have a positive effect on patient adherence to disease-modifying drug therapy in MS care. A range of new strategies is emerging that may help promote optimal disease management.
BACKGROUND: Shared decision making (SDM) and adherence to treatment are an integral part of multiple sclerosis (MS) care. A collaborative process, SDM actively involves the patient, the health care provider, and an extended network in making treatment decisions. Adherence to disease-modifying drug therapies in patients with MS presents an ongoing challenge for patients and health care providers due to the chronic nature of this disease. This narrative review aims to explore the impact of SDM on adherence based on existing literature and to identify new approaches to optimizing adherence. METHODS: A search was conducted using medical subject heading terms, including decision-making, adherence, shared decision-making, compliance, and patient-centered care. RESULTS: Shared decision making between patients and clinicians promotes adherence to the treatment plan in MS. A proactive SDM approach is based on patient preferences, education, and engagement. Providing credible and accurate sources of information is essential for improving patient engagement. Home monitoring, computerized models, and active patient engagement are a few new approaches to improve adherence in patients with MS. CONCLUSIONS: Shared decision-making interventions can have a positive effect on patient adherence to disease-modifying drug therapy in MS care. A range of new strategies is emerging that may help promote optimal disease management.
Entities:
Keywords:
Adherence; Disease-modifying therapy; Multiple Sclerosis; Shared decision making
Authors: V Devonshire; Y Lapierre; R Macdonell; C Ramo-Tello; F Patti; P Fontoura; L Suchet; R Hyde; I Balla; E M Frohman; B C Kieseier Journal: Eur J Neurol Date: 2011-01 Impact factor: 6.089
Authors: Christian Philipp Kamm; L Barin; C Gobbi; C Pot; P Calabrese; A Salmen; L Achtnichts; J Kesselring; M A Puhan; V von Wyl Journal: J Neurol Date: 2019-10-08 Impact factor: 4.849
Authors: Elena Álvarez-Rodríguez; César Manuel Sánchez-Franco; María José Pérez-Haro; Laura Bello-Otero; Marta Aguado-Valcarcel; Inés González-Suárez Journal: PLoS One Date: 2022-05-13 Impact factor: 3.752
Authors: Jasvinder A Singh; Liana Fraenkel; Candace Green; Graciela S Alarcón; Jennifer L Barton; Kenneth G Saag; Leslie M Hanrahan; Sandra C Raymond; Robert P Kimberly; Amye L Leong; Elyse Reyes; Richard L Street; Maria E Suarez-Almazor; Guy S Eakin; Laura Marrow; Charity J Morgan; Brennda Caro; Jeffrey A Sloan; Bochra Jandali; Salvador R Garcia; Jennifer Grossman; Kevin L Winthrop; Laura Trupin; Maria Dall'Era; Alexa Meara; Tara Rizvi; W Winn Chatham; Jinoos Yazdany Journal: PLoS Med Date: 2019-05-08 Impact factor: 11.069
Authors: Celia Oreja-Guevara; Stanca Potra; Birgit Bauer; Diego Centonze; Maria-Paz Giambastiani; Gavin Giovannoni; Jürg Kesselring; Dawn Langdon; Sarah A Morrow; Jocelyne Nouvet-Gire; Maija Pontaga; Peter Rieckmann; Sven Schippling; Nektaria Alexandri; Jane Shanahan; Heidi Thompson; Pieter Van Galen; Patrick Vermersch; David Yeandle Journal: Adv Ther Date: 2019-09-05 Impact factor: 3.845
Authors: I E H Kremer; P J Jongen; S M A A Evers; E L J Hoogervorst; W I M Verhagen; M Hiligsmann Journal: BMC Med Inform Decis Mak Date: 2021-04-09 Impact factor: 2.796
Authors: Nick Bansback; Judy A Chiu; Rebecca Metcalfe; Emmanuelle Lapointe; Alice Schabas; Marilyn Lenzen; Anthony Traboulsee; Larry D Lynd; Robert Carruthers Journal: Mult Scler J Exp Transl Clin Date: 2021-07-15